These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1246 related articles for article (PubMed ID: 27678427)
1. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012. Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427 [TBL] [Abstract][Full Text] [Related]
2. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan. Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405 [TBL] [Abstract][Full Text] [Related]
3. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010. Wong ND; Chuang J; Zhao Y; Rosenblit PD J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670 [TBL] [Abstract][Full Text] [Related]
4. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients. Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797 [TBL] [Abstract][Full Text] [Related]
5. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004 [TBL] [Abstract][Full Text] [Related]
6. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. Querton L; Buysschaert M; Hermans MP J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779 [TBL] [Abstract][Full Text] [Related]
7. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808 [TBL] [Abstract][Full Text] [Related]
8. Implications of the 2013 ACC/AHA cholesterol guidelines for adults in contemporary cardiovascular practice: insights from the NCDR PINNACLE registry. Maddox TM; Borden WB; Tang F; Virani SS; Oetgen WJ; Mullen JB; Chan PS; Casale PN; Douglas PS; Masoudi FA; Farmer SA; Rumsfeld JS J Am Coll Cardiol; 2014 Dec; 64(21):2183-92. PubMed ID: 25447259 [TBL] [Abstract][Full Text] [Related]
9. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study. Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384 [TBL] [Abstract][Full Text] [Related]
10. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Verma AA; Jimenez MP; Subramanian SV; Sniderman AD; Razak F Circ Cardiovasc Qual Outcomes; 2017 Sep; 10(9):. PubMed ID: 28912201 [TBL] [Abstract][Full Text] [Related]
11. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide. Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067 [TBL] [Abstract][Full Text] [Related]
13. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014. Fan W; Philip S; Granowitz C; Toth PP; Wong ND Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639 [TBL] [Abstract][Full Text] [Related]
14. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers. Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901 [TBL] [Abstract][Full Text] [Related]
15. Limitations of real-world treatment with atorvastatin monotherapy for lowering LDL-C in high-risk cardiovascular patients in the US. Marrett E; Zhao C; Zhang NJ; Zhang Q; Ramey DR; Tomassini JE; Tershakovec AM; Neff DR Vasc Health Risk Manag; 2014; 10():237-46. PubMed ID: 24851051 [TBL] [Abstract][Full Text] [Related]
16. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699 [TBL] [Abstract][Full Text] [Related]
17. Does clinician-reported lipid guideline adoption translate to guideline-adherent care? An evaluation of the Patient and Provider Assessment of Lipid Management (PALM) registry. Lowenstern A; Li S; Navar AM; Virani S; Lee LV; Louie MJ; Peterson ED; Wang TY Am Heart J; 2018 Jun; 200():118-124. PubMed ID: 29898839 [TBL] [Abstract][Full Text] [Related]
18. To what extent do high-intensity statins reduce low-density lipoprotein cholesterol in each of the four statin benefit groups identified by the 2013 American College of Cardiology/American Heart Association guidelines? A VOYAGER meta-analysis. Karlson BW; Palmer MK; Nicholls SJ; Lundman P; Barter PJ Atherosclerosis; 2015 Aug; 241(2):450-4. PubMed ID: 26074319 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of dyslipidemia and lipid goal attainment in statin-treated subjects from 3 data sources: a retrospective analysis. Jones PH; Nair R; Thakker KM J Am Heart Assoc; 2012 Dec; 1(6):e001800. PubMed ID: 23316314 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of Elevated Cardiovascular Risks in Young Adults: A Cross-sectional Analysis of National Health and Nutrition Examination Surveys. Patel KK; Taksler GB; Hu B; Rothberg MB Ann Intern Med; 2017 Jun; 166(12):876-882. PubMed ID: 28505660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]